Status regarding Novo Nordisk's holding of its own

Bagsværd, Denmark, 3 July 2017 - In continuation of the company's announcements dated 2 February 2017 and 3 May 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 June 2017 owned 26,782,349 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,356,470 or 1.1% of the total share capital.

In the second quarter of 2017 a total of 13,768,358 B shares were repurchased, and 17,871 B shares were disposed to employees in connection with employee incentive programmes.

Further information

Company announcement No 53 / 2017 

http://www.globenewswire.com/NewsRoom/Attachm...c856c83c63